logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
08/02/2026
Citigroup has downgraded Target's price target from $100 to $89.
Latest
5 m ago
According to the AI Fast News of Every Economic News, Huayuan Securities released a research report on February 8th, giving a "buy" rating to Xinrui Dairy (002946.SZ). The reasons for the rating mainly include: 1) Xinrui Dairy has achieved national layout and strategic transformation through multiple rounds of mergers and acquisitions; 2) Xinrui Dairy has advantages in the low-temperature milk market with great growth potential in the future; 3) Xinrui Dairy's DTC channel and expansion into the sinking market are expected to help drive performance growth. (Every Economic News)
6 m ago
Every Economy AI Flash, Pacific Securities released a research report on February 8th, giving a "buy" rating to Korui International (300662.SZ). The rating reasons mainly include: 1) From the median of the forecast, the core operating profit growth rate of Q4 has slowed slightly; 2) Main business is stable, structural optimization; 3) Overseas business has successfully reversed losses; 4) The core AI strategy "HeWa" platform is growing rapidly. (Daily Economic News)
7 m ago
On February 7th, the total social inter-regional personnel flow reached 22.251 million people.
8 m ago
Every Investment AI Flash, Open Source Securities released a research report on February 7, giving DeYuan Pharmaceutical (920735.SH) a "buy" rating. The reasons for the rating include: 1) full efforts to expand the market, sales of "Fu Rutong" and "Bo Kaiqing" increasing, supplying the tenth batch of centralized procurement products; 2) by 2025, obtaining registration approvals for 8 varieties of drugs, with the adaptation indication of DYX116 for hypoglycemia undergoing phase I clinical trials. (Daily Economic News)
27 m ago
The overall situation of infectious disease epidemic in our country is generally stable, with influenza in most areas dropping to moderate or low levels.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.